These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15662156)

  • 1. The effectiveness of risperidone in the treatment of three children with feeding disorders.
    Berger-Gross P; Coletti DJ; Hirschkorn K; Terranova E; Simpser EF
    J Child Adolesc Psychopharmacol; 2004; 14(4):621-7. PubMed ID: 15662156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case series of eight aggressive young children treated with risperidone.
    Cesena M; Gonzalez-Heydrich J; Szigethy E; Kohlenberg TM; DeMaso DR
    J Child Adolesc Psychopharmacol; 2002; 12(4):337-45. PubMed ID: 12625994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone for young children with mood disorders and aggressive behavior.
    Schreier HA
    J Child Adolesc Psychopharmacol; 1998; 8(1):49-59. PubMed ID: 9639079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.
    Troost PW; Lahuis BE; Steenhuis MP; Ketelaars CE; Buitelaar JK; van Engeland H; Scahill L; Minderaa RB; Hoekstra PJ
    J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1137-44. PubMed ID: 16239862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
    Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT
    J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders.
    Lindsay RL; Leone S; Aman MG
    Clin Pediatr (Phila); 2004 Jun; 43(5):437-44. PubMed ID: 15208748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in the treatment of choreiform movements and aggressiveness in a child with "PANDAS".
    Kleinsasser BJ; Misra LK; Bhatara VS; Sanchez JD
    S D J Med; 1999 Sep; 52(9):345-7. PubMed ID: 10522469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status.
    Kalkan Ucar S; Ozbaran B; Demiral N; Yuncu Z; Erermis S; Coker M
    Brain Dev; 2010 Feb; 32(2):156-61. PubMed ID: 19217229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive risperidone in the treatment of generalized anxiety disorder: a double-blind, prospective, placebo-controlled, randomized trial.
    Pandina GJ; Canuso CM; Turkoz I; Kujawa M; Mahmoud RA
    Psychopharmacol Bull; 2007; 40(3):41-57. PubMed ID: 18007568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in pervasive developmental disorders.
    Erickson CA; Stigler KA; Posey DJ; McDougle CJ
    Expert Rev Neurother; 2005 Nov; 5(6):713-9. PubMed ID: 16274329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting risperidone in stable patients with schizoaffective disorder.
    Mohl A; Westlye K; Opjordsmoen S; Lex A; Schreiner A; Benoit M; Bräunig P; Medori R
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone-associated steatohepatitis and excessive weight-gain.
    Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
    Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective evaluation of adjunctive risperidone treatment in severely behaviorally disordered boys receiving psychosocial treatment.
    Caldwell MF; Malterer M; Umstead D; McCormick DJ
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):34-43. PubMed ID: 18294087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open clinical trial of risperidone monotherapy in young children with autistic disorder.
    Findling RL; Maxwell K; Wiznitzer M
    Psychopharmacol Bull; 1997; 33(1):155-9. PubMed ID: 9133768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome.
    Araki S; Ohji T; Shiota N; Dobashi K; Shimono M; Shirahata A
    Pediatr Int; 2010 Feb; 52(1):e1-3. PubMed ID: 20158635
    [No Abstract]   [Full Text] [Related]  

  • 19. Risperidone approved for the treatment of serious behavioral problems in children with autism.
    Scahill L; Koenig K; Carroll DH; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Aug; 20(3):188-90. PubMed ID: 17688557
    [No Abstract]   [Full Text] [Related]  

  • 20. Separation anxiety in children and adolescents treated with risperidone.
    Hanna GL; Fluent TE; Fischer DJ
    J Child Adolesc Psychopharmacol; 1999; 9(4):277-83. PubMed ID: 10630458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.